JMJD3 Polyclonal antibody

JMJD3 Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human and More (2)

Applications

WB, ELISA

Conjugate

Unconjugated

Cat no : 55354-1-AP

Synonyms

JMJD3, KDM6B, KIAA0346, Lysine-specific demethylase 6B



Tested Applications

Positive WB detected inA549 cells, HeLa cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2400
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Published Applications

WBSee 6 publications below

Product Information

55354-1-AP targets JMJD3 in WB, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman, mouse, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen Peptide
Full Name jumonji domain containing 3, histone lysine demethylase
Calculated Molecular Weight 177 kDa
Observed Molecular Weight 177 kDa
GenBank Accession NumberNM_001080424
Gene Symbol JMJD3
Gene ID (NCBI) 23135
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

JMJD3, also known as KDM6B, is a 1643 amino acid protein, which belongs to the UTX family. JMJD3 is a Histone demethylase that specifically demethylates 'Lys-27' of histone H3, thereby playing a central role in histone code (PubMed:17825402, PubMed:17851529, ). JMJD3 demethylates trimethylated and dimethylated H3 'Lys-27', so it Plays a central role in regulation of posterior development, by regulating HOX gene expression (PubMed:17851529). Histone demethylases are epigenetic actors with a crucial role in cancer by acting as suppressors of tumors or as oncogenes. JMJD3 and UTX (ubiquitously transcribed tetratricopeptide repeat, X chromosome) are transcription activators, being specific H3K27me3 demethylases. JMJD3 is involved in many cellular process such as development, differentiation, senescence and aging by p16, p53 and RB pathways and finally inflammation. Depending on cancer type, JMJD3 expression is increased (prostate and breast cancers, melanoma, gliomas, renal cell carcinoma or decreased (lung, liver, pancreatic, colon and colorectal cancers. This role in carcinogenesis has allowed the development of "epidrugs" to modulate JMJD3 expression (PMID: 29805743 ).

Protocols

Product Specific Protocols
WB protocol for JMJD3 antibody 55354-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Inflammation

Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Ameliorates the Inflammatory Response in Periodontal Disease.

Authors - Rong Song
mouseWB

Gene

miR-148a-3p regulates adipocyte and osteoblast differentiation by targeting lysine-specific demethylase 6b.

Authors - Lijie Tian
mouseWB

J Physiol

Histone demethylase UTX is a therapeutic target for diabetic kidney disease.

Authors - Hong Chen
ratWB

Stem Cells Dev

Inhibition of Ezh2 In Vitro and the Decline of Ezh2 in Developing Midbrain Promote Dopaminergic Neurons Differentiation Through Modifying H3K27me3.

Authors - Feng Hong
humanWB

Oncol Rep

Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylation.

Authors - Zhen Xiao
mouseWB

Nat Cardiovasc Res

α-Ketoglutarate promotes cardiomyocyte proliferation and heart regeneration after myocardial infarction

Authors - Yu Shi